Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    1201 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 56
    1202 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 22
    1203 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
    1204 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 65
    1205 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1206 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Sweden 73
    1207 Apheresis Allogeneic NK LGL Leukemia Hematology 2025 Standard Therapy USA 42
    1208 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 29
    1209 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
    1210 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1211 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Czechia 64
    1212 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 10
    1213 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Brazil 57
    1214 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 21
    1215 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Lithuania 54
    1216 Apheresis Allogeneic Richter Transformation From CLL Hematology 2025 Standard Therapy Poland 55
    1217 Apheresis Allogeneic Richter Transformation From CLL Hematology 2025 Standard Therapy Poland 63
    1218 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1219 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 55
    1220 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 26
    1221 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy NETHERLANDS 63
    1222 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 33
    1223 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy KAZAKHSTAN 10
    1224 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Italy 53
    1225 Apheresis Allogeneic Hodking Lymphoma Hematology 2025 Standard Therapy Belgium 62
    1226 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 54
    1227 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
    1228 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Spain 47
    1229 Apheresis Allogeneic T-Cell Lymphoma Hematology 2025 Standard Therapy Poland 25
    1230 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Portugal 62
    1231 Apheresis Autologous No Data Hematology 2025 Standard Therapy Portugal 65
    1232 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 38
    1233 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 60
    1234 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 65
    1235 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 61
    1236 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 41
    1237 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 73
    1238 Apheresis Autologous T-Cell Lymphoma Hematology 2025 Standard Therapy Germany 49
    1239 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 61
    1240 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy United Kingdom 2
    1241 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 20
    1242 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 5
    1243 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy USA 2
    1244 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Slovakia 56
    1245 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1246 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 60
    1247 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 64
    1248 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 42
    1249 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 63
    1250 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 59
    1251 Apheresis Allogeneic Myelodysplasia Hematology 2025 Standard Therapy Germany 47
    1252 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 58
    1253 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 76
    1254 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 55
    1255 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
    1256 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1257 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 51
    1258 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy United Kingdom 56
    1259 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Italy 62
    1260 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Norway 59
    1261 Apheresis Allogeneic Myeloid Sarcoma Hematology 2025 Standard Therapy Ukraine 24
    1262 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 63
    1263 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 58
    1264 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1265 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
    1266 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 71
    1267 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 62
    1268 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 5
    1269 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Turkey 2
    1270 Apheresis Allogeneic Hodgkin's Lymphoma (HL) Hematology 2025 Standard Therapy South Africa 38
    1271 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Poland 60
    1272 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
    1273 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
    1274 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy NETHERLANDS 72
    1275 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 74
    1276 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 72
    1277 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 19
    1278 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 62
    1279 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Switzerland 25
    1280 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy USA 69
    1281 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 64
    1282 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Lithuania 55
    1283 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Greece 42
    1284 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 55
    1285 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 49
    1286 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 63
    1287 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Portugal 68
    1288 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 41
    1289 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 64
    1290 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 68
    1291 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
    1292 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 73
    1293 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 39
    1294 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 73
    1295 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 57
    1296 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy BELARUS 22
    1297 Apheresis Allogeneic Other Leukemia Hematology 2025 Standard Therapy Belgium 60
    1298 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 48
    1299 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 20
    1300 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Lithuania 51